Last reviewed · How we verify

NCT06321809

Intensive Lifestyle Interventions to Overweight and Obese Patients in Primary Care

Completed Results posted Last updated 4 February 2025
What this trial tests

trial testing intensive lifestyle in Obesity in 165 participants. Completed in 1 December 2022.

Timeline
25 January 2022
Primary endpoint
1 October 2022
1 December 2022

Quick facts

Lead sponsorDuygu Ayhan Baser
StatusCompleted
Study typeOBSERVATIONAL
Enrollment165
Start date25 January 2022
Primary completion1 October 2022
Estimated completion1 December 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Duygu Ayhan Baser

Who can join

Adults 18 to 40, any sex, with Obesity or Life Style. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Primary Outcome Primary · 3 months

Turkish version of the Impact of Weight on Quality of Life-Lite Version (IWQOL) scale was used. The scale has a minimum score of 0 and a maximum of 100. The scoring system is valid for both the scale subgroups and the scale total score. Based on the scale scoring, quality-of-life decreases as the score decreases.

Physical function (baseline)
GroupValue95% CI
Intervention Group68.180 – 93.18
Control-1 Group68.184.55 – 97.73
Control-2 Group70.459.09 – 100
Self-esteem (baseline)
GroupValue95% CI
Intervention Group500 – 100
Control-1 Group57.140 – 96.43
Control-2 Group500 – 100
Sexual life (baseline)
GroupValue95% CI
Intervention Group750 – 100
Control-1 Group87.500 – 100
Control-2 Group81.250 – 100
Public distress (baseline)
GroupValue95% CI
Intervention Group9015 – 100
Control-1 Group8510 – 100
Control-2 Group850 – 100
Work (baseline)
GroupValue95% CI
Intervention Group750 – 100
Control-1 Group87.500 – 100
Control-2 Group87.500 – 100
Total Score (baseline)
GroupValue95% CI
Intervention Group63.7916.38 – 95.69
Control-1 Group73.2828.45 – 93.97
Control-2 Group69.8318.97 – 99.14
Physical function (3 months)
GroupValue95% CI
Intervention Group79.540 – 100
Control-1 Group77.2722.73 – 100
Control-2 Group84.090 – 100
Self-esteem (3 months)
GroupValue95% CI
Intervention Group750 – 100
Control-1 Group82.140 – 100
Control-2 Group60.713.57 – 100
Secondary Secondary · 3 months

Comparing the anthropometric measurements of the three groups at baseline and week 12.

Weight (kg) (Baseline)
GroupValue95% CI
Intervention Group89.5066.10 – 125.80
Control-1 Group84.5061.90 – 135
Control-2 Group85.1064.20 – 108.40
Fat mass (kg) (Baseline)
GroupValue95% CI
Intervention Group33.5013 – 63.60
Control-1 Group28.7017.20 – 48.80
Control-2 Group26.8011.30 – 51.50
Fat free mass (kg) (Baseline)
GroupValue95% CI
Intervention Group52.8043.10 – 83.30
Control-1 Group5041.70 – 89.20
Control-2 Group53.4040.70 – 78.60
Weight (kg) (3 months)
GroupValue95% CI
Intervention Group8865.60 – 128.60
Control-1 Group79.9058.80 – 135
Control-2 Group8462.30 – 108.40
Fat mass (kg) (3 months)
GroupValue95% CI
Intervention Group31.1013 – 64.20
Control-1 Group28.8011.40 – 47.50
Control-2 Group25.205 – 51.50
Fat free mass (kg)(3 months)
GroupValue95% CI
Intervention Group51.9043.40 – 82
Control-1 Group48.5037.10 – 89.20
Control-2 Group53.8041.90 – 75.30
BMI (kg/m2) Secondary · 3 months

Comparing the BMI of the three groups at baseline and week 12.

BMI (kg/m2) (Baseline)
GroupValue95% CI
Intervention Group31.5025 – 47.30
Control-1 Group30.5025.30 – 43.20
Control-2 Group29.7025 – 42.30
BMI (kg/m2) (3 months)
GroupValue95% CI
Intervention Group30.6024.30 – 48.40
Control-1 Group29.5023 – 42.80
Control-2 Group29.2024.80 – 42.30
Waist Circumference (cm) Secondary · 3 months

Comparing the Waist Circumference measurements of the three groups at baseline and week 12.

Waist circumference (cm) (Baseline)
GroupValue95% CI
Intervention Group10685.50 – 140
Control-1 Group101.5077 – 158
Control-2 Group10186 – 132
Waist circumference (cm) (3 months)
GroupValue95% CI
Intervention Group10280 – 141
Control-1 Group10070 – 158
Control-2 Group10080.80 – 132
Lipid Profile Secondary · 3 months

Lipid profile of the three groups at baseline and week 12.

Triglyceride (Baseline)
GroupValue95% CI
Intervention Group10535 – 375
Control-1 Group11039 – 231
Control-2 Group9450 – 335
Total cholesterol (Baseline)
GroupValue95% CI
Intervention Group188141 – 266
Control-1 Group193131 – 284
Control-2 Group18199 – 315
LDL cholesterol (Baseline)
GroupValue95% CI
Intervention Group12168 – 180
Control-1 Group12071 – 181
Control-2 Group12674 – 231
HDL cholesterol (Baseline)
GroupValue95% CI
Intervention Group4530 – 84
Control-1 Group5031 – 90
Control-2 Group4628 – 69
Triglyceride (3 months)
GroupValue95% CI
Intervention Group10036 – 503
Control-1 Group9845 – 230
Control-2 Group9649 – 657
Total cholesterol (3 months)
GroupValue95% CI
Intervention Group189120 – 282
Control-1 Group189111 – 256
Control-2 Group173105 – 324
LDL cholesterol (3 months)
GroupValue95% CI
Intervention Group12870 – 193
Control-1 Group12581 – 174
Control-2 Group12988 – 258
HDL cholesterol (3 months)
GroupValue95% CI
Intervention Group5033 – 87
Control-1 Group4831 – 88
Control-2 Group4827 – 67

Sponsor's own description

The goal of this clinical trial is to compare in the effect of different lifestyle interventions in overweight and obese participants. The main questions it aims to answer are: * effect on anthropometric measurements * effect on lipid profile * effect on weight-related quality of life * observe the differences between interventions The study participants were stratified into three groups: intervention, control-1, and control-2. * Intervention group: They were given a calorie-restricted diet and exercise plan by a dietician or physiotherapist at their first visit, and were followed up by telephone calls at weeks 2, 4, 6, 8 and 10 over 12 weeks. * Control-1 group: During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4. * Control-2 group: The participants were not provided with any programme, and the importance of weight loss was emphasised by the family physicians. Dietary and physical activity advice was given according to the recommendations in the Turkish Endocrine and Metabolism Association 2019 Obesity Diagnosis and Treatment Guide, and was followed up with phone calls at weeks 2, 4, 6, 8 and 10 over a 12-weeks.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Effects of Different Intervention Protocols on Anthropometric Measures, Lipid Profile, and Quality of Life: Insights from a Pandemic-Era Randomized Controlled Trial.
    Ozdemir DC, Baser DA, Fidanci I, Karagoz AD, et al · · 2025 · PMID 41277922 · DOI 10.18502/ijph.v54i9.19860

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06321809.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing